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Abstract 
Background: Venous–arterial carbon dioxide  (CO2) to arterial–venous oxygen  (O2) 
content difference ratio (Cv-aCO2/Ca-vO2) > 1 is supposed to be both sensitive and 
specific for anaerobic metabolism. What regional hemodynamic and metabolic param-
eters determine the ratio has not been clarified.
Objectives: To address determinants of systemic and renal, spleen, gut and liver 
Cv-aCO2/Ca-vO2.
Methods: Post hoc analysis of original data from published experimental studies 
aimed to address effects of different fluid resuscitation strategies on oxygen transport, 
lactate metabolism and organ dysfunction in fecal peritonitis and endotoxin infusion, 
and from animals in cardiac tamponade or hypoxic hypoxia. Systemic and regional 
hemodynamics, blood flow, lactate uptake, carbon dioxide and oxygen-derived vari-
ables were determined. Generalized estimating equations (GEE) were fit to assess 
contributors to systemic and regional Cv-aCO2/Ca-vO2.
Results: Median (range) of pooled systemic Cv-aCO2/Ca-vO2 in 64 pigs was 1.02 (0.02 
to 3.84). While parameters reflecting regional lactate exchange were variably associated 
with the respective regional Cv-aCO2/Ca-vO2 ratios, only regional ratios were indepen-
dently correlated with systemic ratio: renal Cv-aCO2 /Ca-vO2 (β = 0.148, 95% CI 0.062 to 
0.234; p = 0.001), spleen Cv-aCO2/Ca-vO2 (β = 0.065, 95% CI 0.002 to 0.127; p = 0.042), 
gut Cv-aCO2/Ca-vO2 (β = 0.117, 95% CI 0.025 to 0.209; p = 0.013), liver Cv-aCO2/Ca-vO2 
(β = − 0.159, 95% CI − 0.297 to − 0.022; p = 0.023), hepatosplanchnic Cv-aCO2/Ca-vO2 
(β = 0.495, 95% CI 0.205 to 0.786; p = 0.001).
Conclusion: In a mixed set of animals in different shock forms or during hypoxic 
injury, hepatosplanchnic Cv-aCO2/Ca-vO2 ratio had the strongest independent associa-
tion with systemic Cv-aCO2/Ca-vO2, while no independent association was demon-
strated for lactate or hemodynamic variables.
Keywords: Lactate, Lactate kinetics, Resuscitation, Oxygen consumption, Carbon 
dioxide, Septic shock, Multiple organ failure, Hypoxia
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Background
Circulatory shock can be defined as a condition where tissue oxygen delivery does not 
meet the metabolic needs [1]. Inadequate oxygen delivery may also occur with normal 
perfusion when arterial oxygen content is critically reduced, e.g., in severe respiratory 
failure or at high altitude. In septic shock, both global perfusion and arterial oxygen con-
tent can be normal, but the metabolic needs may still be insufficiently met as a result of 
oxygen extraction and/or utilization abnormalities [2]. In all of these conditions, regional 
blood flow may be redistributed as a consequence of central (e.g., sympathetic nervous 
system) and/or peripheral (e.g., nitric oxide, shear stress) adaptive mechanisms [3].
In clinical practice, lactate is commonly used as an indicator of adequacy of tissue 
perfusion [4]. The recently released sepsis-3 definition includes increased blood lactate 
concentration as a criterion for the diagnosis of septic shock [1]. However, lactate con-
centration can also increase as a result of impaired ability of the liver to extract lactate 
[5] or as a consequence of increased aerobic lactate production, e.g., when epinephrine 
is used to stabilize hemodynamics [6].
When tissue oxygen delivery falls under a critical threshold, oxygen consumption 
and  CO2 production from aerobic metabolism decrease [7]. Since some  CO2 is pro-
duced from anaerobic metabolism,  CO2 production falls less than  O2 consumption and 
therefore, their ratio increases [7]. The combination of venous–arterial  CO2 to arterial–
venous  O2 content difference ratio (Cv-aCO2/Ca-vO2) with arterial lactate levels has 
been reported to correlate with Sequential Organ Failure Assessment (SOFA) score and 
mortality [8].
Venous–arterial  CO2 partial pressure to arterial–venous  O2 content difference ratio 
(Pv-aCO2/Ca-vO2) is a relatively easily obtainable surrogate of the Cv-aCO2/Ca-vO2: 
 pO2 and  PCO2, oxygen saturation  (SO2) and hemoglobin (Hb) are widely available in all 
modern blood gas analyzers, while  CO2 content is not easy to measure or calculate. Pv-
aCO2/Ca-vO2 has been used to predict systemic hyperlactatemia in critically ill patients 
[9]. However, it has been shown that decreased blood flow, rather than tissue hypoxia/
dysoxia is the main determinant of increased venous–arterial  CO2 gradient (Pv-aCO2) 
[10]. Furthermore, Pv-aCO2 may vary with different values of oxygen saturation due to 
Haldane effect, and due to changes in dissociation curves if pH, hemoglobin or tempera-
ture is changing. Accordingly, Pv-aCO2 may vary at constant total  CO2 content [11].
What circulatory or metabolic parameters are best associated with systemic (Cv-
aCO2/Ca-vO2) remains unclear. The aim of the present study was to address potential 
determinants of systemic and regional (renal, spleen, gut and liver) Cv-aCO2/Ca-vO2 in 
a mixed set of animals in different shock forms or during hypoxic injury. We hypothe-
sized that parameters of hepatosplanchnic perfusion and metabolism are best predicting 
changes in systemic Cv-aCO2/Ca-vO2.
Methods
We used original data from previously published studies [5, 12, 13]. They were per-
formed in accordance with the National Institutes of Health guidelines for the care and 
use of experimental animals and with the approval of the Animal Care Committee of the 
Canton of Bern, Switzerland.
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The first study (COHORT-1) was designed to address the impact of two different fluid 
resuscitation strategies (moderate-volume and high-volume replacement) on mortality, 
sepsis-associated organ dysfunction and mitochondrial function in animals submitted to 
either fecal peritonitis or endotoxin infusion [12].
The second study (COHORT-2) was performed to evaluate oxygen transport, lactate 
handling and mitochondrial function in animals challenged with fecal peritonitis, car-
diac tamponade or hypoxic hypoxia [5, 13].
In both studies, animals were followed until 24 h after randomization or until death, if 
earlier. After 24 h, animals were euthanized with an overdose of potassium chloride [5, 
12, 13]. The full study protocols of original studies can be found elsewhere [5, 12, 13].
Surgical preparation
With animals in supine position, a midline laparotomy was performed and abdominal 
cavity exposed [5, 12, 13]. Catheters for pressure monitoring and blood sampling were 
inserted into the carotid, hepatic and pulmonary arteries and into jugular, hepatic, por-
tal, renal, mesenteric and splenic veins [5, 12, 13]. A large bore catheter for fluid adminis-
tration was inserted into the femoral vein. Ultrasound Doppler flow probes  (Transonic® 
Systems Inc., Ithaca, NY, USA) were placed around the carotid, superior mesenteric, 
hepatic, splenic and renal arteries, celiac trunk and around the portal vein [5, 12, 13]. 
A drainage catheter was inserted into the urinary bladder. Finally, two large bore drains 
were inserted via both flanks of the animals. The surgical procedure was followed by a 
12-h period of hemodynamic stabilization [5, 12, 13].
Experimental protocol COHORT‑1
After a 12-h period of hemodynamic stabilization, animals were randomized into six 
groups (n = 8 each, total 48 pigs) as follows: fecal peritonitis, endotoxin, or controls, 
each with either moderate-volume fluid resuscitation (10  ml/kg/h of Ringer’s lactate) 
or high [15 ml/kg/h Ringer’s lactate + 5 ml/kg/h hydroxyethyl starch (HES) 130/04, 6% 
 (Voluven®, Fresenius, Stans, Switzerland)] for 24 h or until death, if earlier [12].
Fecal peritonitis was induced by peritoneal instillation through a peritoneal drainage 
tube of 1 g per kg body weight of autologous feces dissolved in 200 ml glucose 5% solu-
tion [12]. In the other groups, the same amount of sterile glucose solution was instilled. 
The intra-peritoneal drains were maintained clamped during the following 6 h [12]. In 
the endotoxin groups, endotoxin (lipopolysaccharide from Escherichia coli 0111:B4, 
20 mg/l in 5% dextrose;  Sigma®, Steinheim, Germany) was infused into the right atrium 
[12].
Experimental protocol COHORT‑2
After 12-h period of hemodynamic stabilization, animals were randomized for a 24-h 
experiments into four groups (n = 8 each; total 32 pigs) as follow: fecal peritonitis, car-
diac tamponade, hypoxic hypoxia, and controls [5, 13]. Following the 3R principles, 
COHORT-1 and 2 studies shared the control (n = 8) and fecal peritonitis groups (n = 8).
Fecal peritonitis was induced by instilling 1 g per kg body weight of autologous feces, 
dissolved in warmed glucose solution, in the abdominal cavity. In the other groups, the 
same amount of sterile glucose solution was instilled. The intra-peritoneal drains were 
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clamped during the first 6 h [5, 13]. Cardiac tamponade was induced by filling the peri-
cardial sac with HES 130/04, 6%  (Voluven®, Fresenius Kabi, Bad Homburg, Germany) 
through the catheter positioned during the operation, aiming at a cardiac output of 
60 ml/kg/min at 6 h, 50 ml/kg/min at 12 h, 40 ml/kg/min at 18 h, and 30 ml/kg/min at 
24 h, respectively [13]. Hypoxic hypoxia was induced by reducing the fraction of inspired 
oxygen  (FiO2) to 21% at 6 h, 18% at 12 h, 17% at 18 h, and 16% at 24 h [13]. When  FiO2 
was reduced below 21%, nitrogen was added to the gas mix. All pigs received Ringer’s 
lactate solution (10 ml/kg/h) during the experiment [13].
Blood measurements
Blood samples for the measurement of hemoglobin (OSM3, Pig module, Radiometer, 
Copenhagen, Denmark), blood gases (ABL 520, Radiometer, Copenhagen, Denmark), 
and lactate (YSI 2300 Stat Plus, Yellow Springs Instruments, CA, USA) were taken at 
baseline and after 3, 6, 12, 18 and 24 h from pulmonary and carotid arteries, and from 
hepatic, portal, renal, mesenteric and splenic veins [5, 12, 13]. Blood sampling was also 
performed before 24  h if the animals exhibited a persistent decrease in mean arterial 
pressure (MAP) below 50 mmHg; these samples were considered as end values [5, 12, 
13].
Calculations
Systemic oxygen delivery  (DO2) and consumption  (VO2) and  CO2 variables were calcu-
lated according the standard formulas as follows [5, 12, 13]:
• DO2 = CaO2 × CO
• VO2 = (CaO2 − CvO2) × CO
• O2ER = (CaO2 − CvO2)/CaO2
• CaO2 = (Hb × SaO2 × 1.34) × (PaO2 × 0.0031)
• CvO2 = (Hb x  SvO2 × 1.34) × (PvO2 × 0.0031)
• Da-vO2 = CaO2 − CvO2
• Pv-aCO2 = PvCO2 − PaCO2,
where CO represents cardiac output expressed in ml/kg/min, Hb represents hemo-
globin expressed in g/dl,  O2ER represents the oxygen extraction ratio,  CaO2 and  CvO2 
represent the arterial and venous  O2 content expressed in ml/dl and  PaCO2 and  PvCO2 
represent, respectively, arterial and venous  CO2 partial pressures expressed in mmHg. 
 CO2 contents were calculated according to the Douglas formula [11]:
• Plasma  CO2 solubility (S) = 0.0307 + [0.00057 × (37 – T)] + [0.00002 × (37 − T)2], 
were temperature (T) is expressed as °C.
• pK’ = 6.086 + [0.042 × (7.4 − pH)] + [(38 − T) × {0.00472 + [0.00139 × (7.4 − pH)]}
], were (pK’) is the apparent dissociation constant of carbonic acid, and (pH) is the 
potential of hydrogen (acidity).
• Plasma  CO2 content (plasma  CCO2, ml/dl) = 2.226 × S × plasma  PCO2 × [1 + (10pH–
pK’)], where (S) is the solubility coefficient for  CO2.
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• Blood  CO2 content (Blood  CCO2, ml/dl) = Plasma 
 CCO2 × 1 − {(0.0289 × Hb) ÷ [3.352 − (0.456 × SO2)] × (8.142 − pH)]}, where  SO2 
is the oxygen saturation in the blood.
Time course of blood lactate levels (lactate disappearance) was defined as change in 
blood lactate levels (%) during a 6-h period [14]. Blood lactate exchange were calcu-
lated as follows [5, 14]:
• Hepatic lactate uptake (µmol/kg/min) = hepatic lactate influx − hepatic lactate efflux.
• Hepatic lactate influx (µmol/kg/min) = (portal venous lactate × portal vein blood 
flow) + (arterial lactate × hepatic arterial blood flow).
• Hepatic lactate efflux (µmol/kg/min) = hepatic venous lactate × (portal venous 
blood flow + hepatic arterial blood flow).
• Other regional lactate exchanges (renal, gut and spleen): regional lactate influx–
regional lactate efflux.
• Whole body venous efflux (µmol/kg/min): cardiac output × mixed venous lactate 
concentration.
Statistical analysis
All data are presented as n/n total (%) or median values with range. Normality was 
tested by the Kolmogorov–Smirnov test. Relationship between arterial lactate and base 
excess was assessed in the whole cohort with simple linear regression and Pearson cor-
relation coefficient. Cv-aCO2/Ca-vO2 were compared between the different regions with 
Kruskal–Wallis test followed by pairwise comparisons with Mann–Whitney U test.
To account for longitudinal and correlated response variables, regression analysis 
based on generalized estimating equations  (GEE) were fit to assess contributors to 
regional (renal, spleen, gut and liver) and systemic Cv-aCO2/Ca-vO2. Contributors to 
regional (renal, spleen, gut and liver) Cv-aCO2/Ca-vO2 included into the models were 
perfusion pressure [mean arterial blood pressure (MAP) minus central venous pres-
sure (CVP)], venous hemoglobin, pH,  pCO2,  pO2, base excess and lactate, regional 
blood flow, regional  DO2,  VO2, and  O2ER, regional lactate uptake and lactate gradi-
ent (regional venous lactate–arterial lactate). All regional (renal, spleen, gut and liver) 
predictors showing a p < 0.05 were entered into a final model aiming to address con-
tributors to systemic Cv-aCO2/Ca-vO2. Unstandardized coefficients (β) along with 
their 95% confidence interval (95% CI) were reported.
To perform a sensitivity analyses, the model was re-assessed including only obser-
vations in which systemic Cv-aCO2/Ca-vO2 was higher than 1.0, which indicates 
anaerobic metabolism [7]. To address potential group effects, the experimental group 
(control group, fecal peritonitis, endotoxin infusion, cardiac tamponade and hypoxic 
hypoxia) was introduced as a predictor into the final models.
The SPSS™ (IBM™ Statistical Package for the Social Science version 26.0) were used 
for statistical analyses and GraphPad Prism version 7.0 (GraphPad Software, Califor-
nia, USA) was used for graph plotting.
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Results
Sixty-four domestic pigs (48 from cohort-1, and 16 from cohort-2) of both sexes [weight: 
41.5 (35.0–48.9) kg, median (range)] were included in this study. Overall mortality was 
40.6% (26/64 animals), with a median survival time of 24 (7–24) h. Mortality accordingly 
to experimental study groups is presented in Additional file 1: Table S1.
Systemic hemodynamics, oxygen transport and lactate kinetics
Systemic hemodynamics, oxygen transport, acid–base balance and lactate kinetics from 
each study group have been previously reported [5, 12, 13]. The median of achieved val-
ues at different time points for the whole studied cohort are displayed in Table 1.
Briefly, animals submitted to fecal peritonitis became hypotensive while cardiac out-
put, systemic  DO2 and arterial lactate levels increased. Endotoxin infusion resulted 
increased cardiac output and mean pulmonary artery pressure (MPAP) while systemic 
 VO2 and  O2ER remained stable. Cardiac tamponade animals exhibited systemic arte-
rial hypotension and decreased  DO2 while systemic  O2ER and arterial lactate levels 
increased. Hypoxic hypoxia resulted in increased cardiac output while systemic  DO2 
and  O2ER remained unchanged [5, 12, 13].
Table 1 Systemic hemodynamics, arterial lactate levels and  whole-body venous lactate 
efflux
Values represent median and range. Lactate disappearance (%): initial lactate − final lactate/initial lactate × 100. Whole 
body venous efflux (μmol/kg/min): cardiac output × mixed venous lactate concentration
BL baseline, End of the experiment (at 24 h of resuscitation or before death if earlier), MAP mean arterial blood pressure, 
MPAP mean pulmonary artery pressure, CVP central venous pressure, SVRI systemic vascular resistance index, SvO2 mixed 
venous oxygen saturation, DO2 systemic oxygen delivery, VO2 systemic oxygen consumption and O2ER systemic oxygen 
extraction
Parameters BL 3 h 6 h 12 h 18 h End
Heart rate 
(beats/min)
106 (74–178) 124 (83–214) 142 (81–222) 162 (86–222) 157 (77–200) 149 (74–206)
MAP (mm Hg) 70 (46–117) 78 (40–123) 73 (45–131) 75 (38–116) 74 (33–109) 68 (31–135)
MPAP (mm 
Hg)
17 (11–29) 23 (11–55) 21 (12–37) 24 (14–38) 23 (15–38) 25 (14–43)
CVP (mm Hg) 4 (0–10) 5 (1–12) 6 (2–12) 7 (1–15) 7 (2–14) 8 (2–18)
Cardiac out-
put (ml/kg/
min)
78 (50–120) 88 (38–154) 93 (53–146) 90 (47–202) 101 (40–167) 105 (38–301)
SVRI (mm Hg 
l/kg/min)
836 (501–1347) 869 (346–2274) 808 (408–1972) 776 (410–1249) 684 (151–1471) 598 (198–1315)
SvO2 (%) 50 (33–67) 55 (18–70) 55 (8–75) 55 (19–69) 57 (16–70) 53 (6–73)
DO2 (ml/min) 384 (224–654) 421 (200–991) 447 (236–781) 407 (190–816) 441 (161–700) 440 (150–980)
VO2 (ml/min) 181 (96–274) 178 (108–310) 184 (109–311) 181 (115–393) 190 (105–282) 197 (105–363)
O2ER 0.48 (0.32–0.66) 0.42 (0.27–0.74) 0.44 (0.23–0.91) 0.43 (0.26–0.75) 0.41 (0.28–0.84) 0.43 (0.24–0.94)
Lactate 
(mmol/l)
0.6 (0.4–2.3) 0.8 (0.2–2.7) 0.7 (0.4–2.2) 0.8 (0.5–3.6) 0.7 (0.4–2.0) 1.0 (0.4–7.0)
Lactate disap-
pearance 
(%)
− 16 (− 286 
to 43)
1 (− 339 to 54) − 5 (− 184 
to 49)
− 7 (− 308 
to 34)
Whole-body 
venous lac-
tate efflux 
(µmol/kg/
min)
47.5 (28.9–
139.0)
68.8 (22.9–
222.6)
71.8 (27.8–
301.4)
70.8 (30.0–
183.4)
79.9 (30.4–
237.8)
91.9 (29.3–
513.8)
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Systemic carbon dioxide and oxygen variables
Acid–base balance from each study group have been previously reported [5, 12, 13]. 
Base excess inversely correlated with arterial lactate levels (r = − 0.65, p < 0.001; Addi-
tional file 1: Figure S1). The median of achieved values at different time points for the 
whole studied cohort are displayed in Table 2.
Median of pooled systemic Cv-aCO2/Ca-vO2 was 1.02 (0.02 to 3.84). During the 
experimental period, median Cv-aCO2 and Ca-vO2 decreased while their ratio 
remained unchanged (Table 2).
Systemic Cv-aCO2/Ca-vO2 was neither correlated with arterial lactate (β = 0.22, 
95% CI − 0.16 to 0.61; p = 0.249), lactate disappearance (β = − 5.65, 95% CI − 38.0 to 
26.7; p = 0.732) nor with whole-body venous lactate efflux (β = 5.31, 95% CI − 15.6 to 
26.2; p = 0.619) (Fig. 1).
Table 2 Arterial blood gas analysis, hemoglobin and systemic carbon dioxide and oxygen 
variables
Values represent median and range. BL = baseline, End = end of experiment after 24 h of randomization or before death 
if earlier.  PaO2 = arterial oxygen partial pressure,  PaCO2 = arterial carbon dioxide partial pressure,  SpO2 = peripheral 
oxygen saturation,  CaCO2 = arterial  CO2 content,  CvCO2 = venous  CO2 content, Cv-aCO2 = venous–arterial  CO2 content 
difference, Pv-aCO2 = venous-to-arterial carbon dioxide difference,  CaO2 = arterial  O2 content,  CvO2 = venous  O2 content, 
Ca-vO2 = arterial–venous  O2 content difference, Cv-aCO2/Ca-vO2 = venous–arterial  CO2 to arterial–venous  O2 content 
difference ratio, Pv-aCO2/Ca-vO2 = ratio between venous-to-arterial carbon dioxide difference and arterial–venous oxygen 
content difference
Parameters BL 3 h 6 h 12 h 18 h End
pH 7.48 (7.41–7.53) 7.46 (7.31–7.52) 7.45 (7.29–7.54) 7.44 (7.25–7.58) 7.44 (7.32–7.56) 7.41 (7.18–7.59)
Bicarbonate 
(mmol/l)
27.2 (23.9–29.6) 26.3 (22.0–29.9) 26.2 (21.6–30.8) 26.6 (19.8–30.9) 26.9 (21.8–31.8) 26.9 (13.9–33.5)
Base excess 
(mmol/l)
3.9 (0.1–6.5) 2.8 (− 2.8 to 
6.6)
2.8 (− 2.8 to 
7.4)
3.0 (− 4.9 to 
8.2)
3.2 (− 2.2 to 
8.5)
2.6 (− 9.0 to 8.7)
PaCO2 (mm 
Hg)
37.7 (33.1–41.8) 38.0 (29.7–50.7) 38.6 (31.3–51.5) 39.3 (33.3–53.1) 38.6 (34.0–56.7) 41.1 (17.7–80.3)
PaO2 (mm Hg) 137 (81–177) 119 (49–214) 121 (43–172) 118 (34–183) 127 (38–203) 110 (44–218)
SpO2 (%) 97 (90–100) 96 (69–100) 96 (55–99) 96 (55–98) 96 (50–97) 95 (46–98)
Arterial 
hemoglobin 
(g/dl)
8.9 (6.3–11.2) 9.2 (7.0–13.8) 9.4 (6.4–14.2) 9.1 (6.6–13.5) 8.4 (6.6–13.7) 8.6 (5.2–13.0)
CaCO2 (ml/dl) 56.5 (49.5–61.4) 54.6 (44.5–62.4) 54.9 (44.7–63.5) 55.4 (43.5–64.0) 57.0 (45.4–66.4) 56.0 (28.4–73.5)
CvCO2 (ml/dl) 62.3 (47.2–67.2) 60.0 (51.4–68.3) 59.5 (51.4–69.2) 61.1 (52.0–67.9) 62.0 (52.5–69.4) 61.9 (43.9–75.1)
Cv-aCO2 (ml/
dl)
5.7 (1.9–10.0) 5.5 (0.1–9.6) 5.4 (1.0–10.8) 5.5 (1.8–10.5) 5.5 (2.3–9.7) 5.1 (1.6–19.3)
Pv-aCO2 
(mmHg)
8.4 (0.9–11.7) 8.4 (3.1–15.1) 7.8 (1.7–14.2) 8.9 (2.9–16.7) 8.5 (0.5–18.6) 9.4 (4.6–64.4)
CaO2 (ml/dl) 12.1 (8.7–14.9) 12.3 (8.2–17.5) 12.5 (7.0–18.4) 11.8 (6.6–18.3) 11.2 (5.3–18.2) 10.7 (5.3–17.1)
CvO2 (ml/dl) 6.3 (2.9–8.9) 6.9 (2.1–11.6) 7.1 (1.0–13.5) 6.7 (2.7–11.0) 6.8 (1.5–11.2) 6.1 (0.8–12.8)
Ca-vO2 (ml/l) 5.6 (4.2–8.1) 5.7 (3.5–8.1) 5.2 (2.8–9.2) 5.2 (2.6–9.0) 4.4 (3.0–9.6) 4.6 (2.9–11.8)
Cv-aCO2/
Ca-vO2
1.0 (0.4–1.7) 1.0 (0.0–1.6) 1.0 (0.3–1.8) 1.0 (0.5–1.6) 1.1 (0.5–2.0) 1.0 (0.3–3.8)
Pv-aCO2/
Ca-vO2 
(mmHg ml 
 O2/dl)
1.5 (0.1–2.2) 1.5 (0.8–2.8) 1.5 (0.4–2.1) 1.7 (1.0–2.6) 1.9 (0.1–2.5) 2.0 (1.1–6.2)
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Regional blood flow, lactate uptake and Cv‑aCO2/Ca‑vO2
Median total hepatic blood flow, total hepatosplanchnic blood flow, superior mesenteric 
artery blood flow and spleen artery blood flow increased during the experimental period, 
with maximal values observed at the end of study. Renal artery blood flow remained sta-
ble during experimental period (Table 3). Hepatic lactate uptake and hepatosplanchnic 
lactate uptake increased during the study period and were markedly positive (lactate 
Fig. 1 Scatter plot between systemic venous–arterial  CO2 to arterial–venous  O2 content difference 
ratio (Cv-aCO2/Ca-vO2) and arterial lactate, lactate disappearance and whole-body venous lactate efflux. 
β = unstandardized coefficient, CI = confidence interval, Cv-aCO2/Ca-vO2 = venous–arterial  CO2 to arterial–
venous  O2 content difference ratio, whole-body venous efflux = cardiac output × mixed venous lactate 
concentration, lactate disappearance (%) = initial lactate − final lactate/initial lactate × 100
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Table 3 Regional blood flow, lactate uptake and venous–arterial  CO2 to arterial–venous  O2 
content difference ratio
Parameters BL 3 h 6 h 12 h 18 h End
Total hepatic 
blood flow (ml/
kg/min)
22.3 (9.7–37.8) 22.5 (12.0–35.2) 24.0 (12.0–
41.0)
25.3 (8.7–49.1) 28.3 (9.4–50.3) 27.3 (8.4–55.7)
Total hepato-
splanchnic 
blood flow (ml/
kg/min)
23.7 (14.7–42.9) 23.5 (9.9–39.4) 25.4 (15.1–
40.7)
27.6 (16.5–
50.4)
31.4 (14.0–
55.0)
31.1 (9.7–69.2)
Hepatic lactate 
uptake (µmol/
kg/min)
8.5 (2.1–26.5) 10.0 (3.5–30.1) 9.8 (− 2.4 to 
30.0)
10.9 (0.8–22.4) 9.8 (− 0.5 to 
23.4)
10.8 (− 22.8–
25.4)
Hepatosplanch-
nic lactate 
uptake (µmol/
kg/min)
6.8 (0.0–60.1) 7.4 (− 7.2 to 
43.9)
8.2 (− 3.8 to 
27.6)
8.2 (− 0.7 to 
25.1)
8.2 (− 2.3 to 
33.7)
7.2 (− 32.3–
31.6)
Lactate hepatic 
vein − hepatic 
artery (µmol/l)
− 0.3 (− 1.6 
to 0.0)
− 0.3 (− 1.8 
to 0.4)
− 0.3 (− 1.3 
to 0.1)
− 0.3 (− 1.0 
to 0.0)
− 0.3 (− 1.6 
to 0.2)
− 0.3 (− 1.3 
to 1.4)
Lactate hepatic 
vein − portal 
vein (µmol/l)
− 0.4 (− 0.6 to 
-0.1)
− 0.5 (− 2.1 to 
-0.1)
− 0.4 (− 1.0 
to 0.1)
− 0.4 (− 1.2 
to 0.0)
− 0.4 (− 1.6 
to 0.0)
− 0.4 (− 0.9 
to 1.7)
Hepatic Cv-aCO2/
Ca-vO2
0.7 (0.0–1.6) 0.8 (0.1–3.2) 0.8 (0.1–2.9) 0.8 (0.2–2.2) 0.9 (0.5–2.1) 0.9 (0.2–6.9)
Hepatosplanch-
nic Cv-aCO2/
Ca-vO2
1.0 (0.4–1.5) 1.0 (0.4–2.3) 1.0 (0.7–2.1) 1.0 (0.5–1.5) 1.0 (2.2–1.5) 1.0 (0.2–3.4)
Renal artery 
blood flow (ml/
kg/min)
5.2 (1.4–9.5) 4.8 (1.1–9.3) 4.7 (2.0–12.5) 5.4 (1.7–10.7) 5.4 (1.8–10.4) 4.9 (0.8–11.8)
Renal lactate 
uptake (µmol/
kg/min)
0.0 (− 3.9 to 
8.5)
− 0.2 (− 5.1 
to 6.9)
− 0.6 (− 5.4 
to 1.2)
− 0.4 (− 5.9 
to 3.0)
− 0.7 (− 5.2 
to 3.4)
− 0.2 (− 5.7 
to 6.3)
Renal lactate gra-
dient (µmol/l)
0.0 (− 1.4 to 
1.4)
0.0 (− 1.2 to 
1.0)
0.1 (− 0.3 to 
1.0)
0.1 (− 0.8 to 
1.8)
0.2 (− 0.4 to 
1.0)
0.1 (− 0.9 to 
1.4)
Renal Cv-aCO2/
Ca-vO2
1.2 (0.4–2.8) 1.0 (0.4–2.3) 1.1 (0.1–2.2) 1.2 (0.1–3.2) 1.1 (0.5–2.5) 1.1 (0.3–4.7)
Renal Pv-aCO2/
Ca-vO2 
(mmHg ml 
 O2/dl)
1.4 (0.1–3.1) 1.4 (0.0–3.3) 1.3 (0.2–2.2) 1.7 (0.5–6.0) 1.7 (0.7–3.1) 1.7 (0.7–6.2)
Superior mes-
enteric artery 
blood flow (ml/
kg/min)
15.5 (9.4–35.1) 15.9 (6.9–26.8) 16.7 (8.1–31.9) 17.5 (10.7–
39.9)
18.3 (8.9–43.9) 18.8 (7.1–47.8)
Gut lactate 
uptake (µmol/
kg/min)
− 1.7 
(− 12.9–40.4)
− 2.0 
(− 11.8–20.8)
− 2.0 
(− 22.8–11.0)
− 2.1 
(− 11.3–9.5)
− 2.5 
(− 12.7–4.5)
− 2.6 
(− 12.7–23.2)
Gut lactate gradi-
ent (µmol/l)
0.1 (− 1.2 to 
0.8)
0.1 (− 1.2 to 
0.8)
0.1 (− 0.6 to 
1.3)
0.1 (− 0.5 to 
0.6)
0.1 (− 0.3 to 
0.5)
0.1 (− 1.9 to 
0.8)
Gut Cv-aCO2/
Ca-vO2
1.3 (0.5–3.9) 1.2 (0.3–2.8) 1.3 (0.5–3.0) 1.2 (0.1–2.1) 1.3 (0.4–2.0) 1.2 (0.4–5.0)
Gut Pv-aCO2/
Ca-vO2 
(mmHg ml 
 O2/dl)
2.2 (0.2–6.8) 2.2 (0.7–4.2) 2.5 (1.1–4.0) 2.5 (1.5–4.5) 2.8 (1.5–4.2) 3.0 (1.1–8.4)
Spleen artery 
blood flow (ml/
kg/min)
1.0 (0.2–3.3) 1.0 (0.4–4.6) 1.3 (0.2–4.9) 1.2 (0.2–5.2) 1.3 (0.2–6.6) 1.3 (0.1–8.2)
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extraction). Renal, mesenteric and splenic lactate uptake, which were all slightly negative 
(lactate release), remained stable (Table 3).
Median (range) of pooled hepatic, hepatosplanchnic, renal, mesenteric and spleen Cv-
aCO2/Ca-vO2 were, respectively, 0.82 (0.0–6.9), 1.0 (0.2–3.4), 1.1 (0.1–4.7), 1.2 (0.1–5.0) 
and 1.2 (0.0–6.0) (Additional file  1: Fig.  S2). Values for the whole cohort at different 
time points are displayed in Table 3, and separate values for the individual experimental 
groups in Additional file 1: Fig. S3.
Contributors to regional (renal, spleen, gut and liver) Cv-aCO2/Ca-vO2 for the whole 
cohort are presented in Additional file 1: Tables S2–S5). Contributors to regional (renal, 
spleen, gut and liver) Cv-aCO2 /Ca-vO2 for time points which systemic Cv-aCO2/
Ca-vO2 > 1.0 only are presented in Additional file 1: Tables S6–S9.
Contributors to systemic Cv‑aCO2/Ca‑vO2
Renal Cv-aCO2/Ca-vO2 (β = 0.148, 95% CI 0.062 to 0.234; p = 0.001), spleen Cv-aCO2/
Ca-vO2 (β = 0.065, 95% CI 0.002 to 0.127; p = 0.042), gut Cv-aCO2/Ca-vO2 (β = 0.117, 
95% CI 0.025 to 0.209; p = 0.013), liver Cv-aCO2/Ca-vO2 (β = − 0.159, 95% CI − 0.297 
to − 0.022; p = 0.023) and hepatosplanchnic Cv-aCO2/Ca-vO2 (β = 0.495, 95% CI 0.205 
to 0.786; p = 0.001)— but none of the other parameters—were independently correlated 
with systemic Cv-aCO2/Ca-vO2 (Table 4).
Additional analysis
When only systemic Cv-aCO2/Ca-vO2 > 1.0 were included in the analysis, only renal 
Cv-aCO2/Ca-vO2 (β = 0.099, 95% CI 0.039 to 0.159; p = 0.001), Gut Cv-aCO2/Ca-vO2 
(β = 0.120, 95% CI 0.015 to 0.225; p = 0.025), liver Cv-aCO2/Ca-vO2 (β = − 0.323, 95% CI 
− 0.508 to − 0.138; p = 0.001) and hepatosplanchnic Cv-aCO2/Ca-vO2 (β = 0.641, 95% 
CI 0.274 to 1.008; p = 0.001) remained independently correlated with systemic Cv-aCO2/
Ca-vO2 (Additional file 1: Table S10).
Values represent median and range. BL = baseline, End = end of the experiment (at 24 h of resuscitation or before death if 
earlier). Regional blood flow was expressed as ml/kg/min. Total hepatic blood flow = hepatic arterial blood flow + portal 
vein blood flow, total hepatosplanchnic blood flow = celiac trunk blood flow + superior mesenteric artery blood flow, 
hepatic lactate uptake = hepatic lactate influx − hepatic lactate efflux, hepatosplanchnic lactate uptake = (arterial 
lactate − hepatic venous lactate) * total hepatic blood flow, Cv-aCO2/Ca-vO2 = venous–arterial  CO2 to arterial–venous  O2 
content difference ratio, regional lactate uptake (renal, gut and spleen) = regional lactate influx − regional lactate efflux, 
regional lactate gradient (renal, gut and spleen) = regional venous lactate − arterial lactate, Pv-aCO2/Ca-vO2 = ratio between 
venous-to-arterial carbon dioxide difference and arterial–venous oxygen content difference
Table 3 (continued)
Parameters BL 3 h 6 h 12 h 18 h End
Spleen lactate 
uptake (µmol/
kg/min)
− 0.1 (− 2.1 
to 1.6)
− 0.3 (− 1.6 
to 0.4)
− 0.3 (− 1.7 
to 0.4)
− 0.2 (− 1.1 
to 0.6)
− 0.2 (− 1.4 
to 0.4)
− 0.3 (− 1.8 
to 1.8)
Spleen lactate 
gradient 
(µmol/l)
0.1 (− 1.0 to 
1.1)
0.2 (− 0.8 to 
1.0)
0.2 (− 0.4 to 
1.1)
0.2 (− 0.4 to 
1.1)
0.2 (− 0.3 to 
0.8)
0.2 (− 0.9 to 
2.6)
Spleen Cv-aCO2/
Ca-vO2
1.3 (0.4–3.2) 1.1 (0.3–2.9) 1.2 (0.2–3.1) 1.3 (0.0–5.6) 1.3 (0.3–3.9) 1.1 (0.5–6.0)
Spleen Pv-aCO2/
Ca-vO2 
(mmHg ml 
 O2/dl)
2.2 (0.8–3.2) 2.3 (1.1–6.8) 2.4 (0.1–4.0) 2.4 (1.3–7.5) 2.6 (0.3–5.3) 2.9 (0.3–8.4)
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The inclusion of experimental group (fecal peritonitis, endotoxin infusion, cardiac 
tamponade and hypoxic hypoxia) as a predictor into the final models assessing contribu-
tors to Cv-aCO2/Ca-vO2 did not affect the results (Additional file 1: Tables S11 and S12).
Discussion
We found that variables indicating regional lactate transport and oxygen extraction 
ratios correlated with regional but not systemic Cv-aCO2/Ca-vO2 ratios. The best pre-
dictor of systemic Cv-aCO2/Ca-vO2 ratio was the hepatosplanchnic Cv-aCO2/Ca-vO2 
ratio (β = 0.495), while the other regional ratios correlated also, albeit to a weaker 
extent. If only systemic Cv-aCO2/Ca-vO2 > 1 were included in the analysis, also renal 
and spleen lactate gradients correlated with systemic Cv-aCO2/Ca-vO2 ratios.
In patients with acute lung injury, septic or cardiogenic shock, a Pv-aCO2/
Ca-vO2 > 1.4 predicted hyperlactatemia [9]. In contrast to this study, we aimed to pre-
dict Cv-aCO2/Ca-vO2 ratios from regional blood flows, and lactate and other metabo-
lism related variables. Our findings may be explained by a high regional heterogeneity 
in terms of tolerance to anemic and hypoxic insults [15], and differences in the availa-
bility of adaptive mechanisms among various organs/systems [16]. Therefore, markers 
indicating tissue dysoxia in one organ may be diluted by those of other organs with 
more resources to adapt.
Table 4 Contributors to  systemic venous–arterial  CO2 to  arterial–venous  O2 content 
difference ratio (Cv-aCO2/Ca-vO2) (n = 255)
β = unstandardized coefficient, CI = confidence interval, Cv-aCO2/Ca-vO2 = venous–arterial  CO2 to arterial–venous  O2 
content difference ratio, MAP = mean arterial blood pressure, CVP = central venous pressure,  O2ER = oxygen extraction, 
renal lactate gradient = lactate kidney vein − lactate arterial, spleen lactate gradient = lactate spleen vein − lactate arterial, 
 pO2 = oxygen partial pressure, total hepatic blood flow = hepatic arterial blood flow + portal vein blood flow, hepatic 
lactate uptake = hepatic lactate influx − hepatic lactate efflux, hepatosplanchnic lactate uptake = (arterial lactate − hepatic 
venous lactate) * total hepatic blood flow
Parameters β 95% CI p value
Renal Cv-aCO2/Ca-vO2 0.148 0.062 to 0.234 0.001
Spleen Cv-aCO2/Ca-vO2 0.065 0.002 to 0.127 0.042
Gut Cv-aCO2/Ca-vO2 0.117 0.025 to 0.209 0.013
Liver Cv-aCO2/Ca-vO2 − 0.159 − 0.297 to − 0.022 0.023
Hepatosplanchnic Cv-aCO2/Ca-vO2 0.495 0.205 to 0.786 0.001
MAP-CVP (mmHg) − 0.001 − 0.002 to 0.001 0.364
Base excess kidney vein (mmol/l) 0.001 − 0.012 to 0.014 0.873
Renal  O2ER − 0.025 − 0.271 to 0.221 0.843
Lactate kidney vein (mmol/l) − 0.043 − 0.171 to 0.085 0.510
Renal lactate gradient (mmol/l) 0.104 − 0.036 to 0.245 0.144
Spleen lactate gradient (mmol/l) 0.037 − 0.051 to 0.124 0.411
Gut  O2ER 0.089 − 0.164 to 0.342 0.489
Lactate mesenteric vein (mmol/l) 0.043 − 0.074 to 0.160 0.474
pO2 hepatic vein (mmHg) 0.002 − 0.005 to 0.009 0.563
Total hepatic blood flow (ml/kg/min) − 0.001 − 0.009 to 0.006 0.729
Hepatic  O2ER 0.132 − 0.174 to 0.438 0.397
Hepatic lactate uptake (µmol/kg/min) 0.000 − 0.007 to 0.007 0.969
Hepatosplanchnic lactate uptake (µmol/kg/min) 0.007 0.000 to 0.015 0.059
Lactate hepatic vein − hepatic artery (µmol/l) 0.075 − 0.122 to 0.271 0.456
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In our fluid-resuscitated experimental models, arterial lactate levels increased 
only moderately, and not in all animals. Despite this, we found overall associations 
between lactate-related parameters and Cv-aCO2/Ca-vO2 in all regions. Since the 
regional Cv-aCO2/Ca-vO2 determined systemic Cv-aCO2/Ca-vO2 to some extent, we 
suggest that increasing systemic Cv-aCO2/Ca-vO2 is useful to detect subtle regional 
metabolic alterations, even if values are smaller than 1.
Lactate and lactic acidosis are not exclusively related to anaerobic metabolism [17]. 
Interpretation of lactate in shock and hypoxia has evolved from being a marker of 
anaerobic metabolism, to represent part of an adaptive mechanism to provide an 
alternative substrate to vital organs such as kidney, brain and heart (lactate shut-
tle theory) [18]. Experimental data support the concept that respiratory quotient, 
expressed as the ratio between  CO2 production  (VCO2), and oxygen consumption 
 (VO2) is a reliable marker of anaerobic threshold [19]. Our study found that neither 
arterial lactate, nor lactate disappearance, nor whole-body venous lactate efflux are 
associated with RQ (measured as Cv-aCO2/Ca-vO2), potentially suggesting that lac-
tate may be, at least in part, associated to aerobic metabolism in the hypoxia and 
shock models assessed in this study. The slower lactate kinetics of lactate compared 
to blood gas variables may provide another explanation in some cases, as discussed 
by others [8]. However, our data demonstrate that lactate concentrations > 2 mmol/l 
were almost always associated with negative base excess values. Finally, Cv-aCO2 may 
not increase in states of tissue hypoxia when venous blood flow is high enough to 
wash out  CO2 produced by the hypoxic cells [20].
The hepatosplanchnic region was the most important contributor to systemic Cv-
aCO2/Ca-vO2. It could be argued that this is a consequence of the greater amount of 
tissue perfused in this compared to the other regions. On the other hand, we have 
demonstrated in humans that changes in hepatosplanchnic metabolism and blood 
flow dissociate from those of systemic blood flow and metabolism [21, 22]. Fur-
thermore, one has to acknowledge that blood flow is not a component of Cv-aCO2/
Ca-vO2 values—the main drivers are  pCO2, Hb and  SO2. Therefore, higher rates of 
 CO2 production related to  O2 consumption in the hepatosplanchnic compared to 
other regions could have accounted for the high contribution of hepatosplanchnic 
to systemic Cv-aCO2/Ca-vO2. However, we found that Cv-aCO2/Ca-vO2 ratios were 
lowest in the hepatosplanchnic region. Nevertheless, in low flow and/or high meta-
bolic circumstances, portal venous oxygen content and therefore hepatic oxygen 
delivery will decrease over-proportionally, also because portal flow represents around 
2/3 of total liver perfusion—this renders the region, especially the liver, at risk for 
inadequate oxygen supply [23].
In terms of determinants of systemic Cv-aCO2/Ca-vO2, regional veno-arterial lac-
tate gradients were only significantly associated when Cv-aCO2/Ca-vO2 was > 1 and 
specifically in kidney and spleen. Kidney is an important organ for lactate disposal, 
accounting for about 30% of its systemic turnover. In the kidney, lactate is used for 
gluconeogenesis and as a substrate for ATP production, similarly to brain and heart 
[18, 24]. On the other hand, spleen lactate metabolism is very poorly described. A 
recent paper about inter-organ metabolite exchange metabolomics mapped that 
spleen is one of the organs which the highest production of lactate in the body at rest 
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[25]. In our study, spleen together with mesenteric region was also the organ with 
the highest Cv-aCO2/Ca-vO2 gradients, suggesting that this organ operated at a level 
closer to anaerobic condition than other organs.
Limitations of the present study include the retrospective nature (post hoc analysis of 
previous studies), and a pooling of several models. It seems obvious that evaluation of the 
parameters in each group separately would have resulted in more overt changes over time. 
The drawback of this approach is the relatively small n per group. The advantage of a pooled 
group is the large range of variables and a better simulation of a mixed ICU patient popula-
tion. Conceptually, one would expect that higher lactate concentrations go together with 
higher Cv-aCO2/Ca-vO2 values, independently of group or time point, if both reflect tissue 
hypoxia. Furthermore, we did not find an effect of the model on the association between 
the various parameters with regional or systemic Cv-aCO2/Ca-vO2 ratios. Given the design 
of the original studies and the fixed time points of blood sampling, we could neither deter-
mine how fluid resuscitation in the sepsis models affected regional and systemic Cv-aCO2/
Ca-vO2 ratios, nor the association of Cv-aCO2/Ca-vO2 ratios with signs of systemic inflam-
mation and tissue injury. Therefore, we cannot provide mechanistic explanations for our 
findings—this should be done in further, prospective studies. Lastly, it can be argued, that 
hepatosplanchnic and splenic/mesenteric values are mathematically and physiologically 
coupled, as they share the arterial variables, and because the latter contribute to the for-
mer. By using a strict pre-analysis protocol to obtain blood and measure the parameters 
included in Cv-aCO2/Ca-vO2 values, and by measuring hemoglobin and oxygen satura-
tion with a module specific for pig blood, we believe that measurement errors largely have 
been avoided. We acknowledge that, e.g., mesenteric Cv-aCO2/Ca-vO2 values contribute to 
hepatosplanchnic values—as all regional values contribute to systemic values. In the pre-
sent study, we were interested in Cv-aCO2/Ca-vO2 values of both single organs (spleen, gut, 
kidney) and the whole hepatosplanchnic region—especially also because blood sampling 
from the liver vein is clinically feasible, whereas samples from portal and splenic veins can 
be obtained only intra-operatively. Conversely, strengths are the provision of data where 
data have been lacking so far, and the ethical commitment with the 3R principle (Replace-
ment, Reduction and Refinement) on animal research.
The overall aim of this analysis was to improve our understanding about contributors to 
systemic Cv-aCO2/Ca-vO2 values, since the latter may offer a more specific indicator of 
anaerobic metabolism than lactate. While we found that only regional Cv-aCO2/Ca-vO2 
contributed to the respective systemic values, contributors to regional Cv-aCO2/Ca-vO2 
values differed in the regions (e.g., regional lactate gradient in the kidney, venous independ-
ent of arterial lactate in the gut; MAP-CVP in the hepatosplanchnic region but not in the 
kidney)—especially when regional Cv-aCO2/Ca-vO2 values were > 1. These data are prelim-
inary and have not been prospectively studied. However, we believe they are important for 
hypothesis generation about how different regions can metabolically adapt to insults—and 
about potentially modifiable factors.
Conclusion
In a mixed set of animals in different shock states or with hypoxic injury, regional 
variables representing local lactate transport and oxygen extraction ratios corre-
lated with the respective regional Cv-aCO2/Ca-vO2 ratios. However, only regional 
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Cv-aCO2/Ca-vO2 ratios were independently associated with systemic Cv-aCO2/
Ca-vO2.
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